Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,697 | -3,329 | -3,882 | -839 | -11,155 |
| Depreciation Amortization | 9 | 78 | 226 | 666 | 431 |
| Other Working Capital | 274 | 319 | -4,256 | -2,787 | 4,382 |
| Other Operating Activity | -2,336 | 14,367 | 16,357 | 298 | 326 |
| Operating Cash Flow | $-5,750 | $11,435 | $8,445 | $-2,662 | $-6,016 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,811 | 4,496 |
| PPE Investments | -21 | 225 | -49 | -1 | -57 |
| Other Investing Activity | -169 | 936 | -1,261 | -188 | -157 |
| Investing Cash Flow | $-190 | $1,161 | $-1,310 | $1,622 | $4,282 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 27 | 50 | 139 |
| Common Stock Repurchased | -13,954 | -49 | N/A | N/A | N/A |
| Other Financing Activity | -316 | -284 | 0 | 0 | 0 |
| Financing Cash Flow | $-14,270 | $-333 | $27 | $50 | $139 |
| Beginning Cash Position | 20,946 | 8,683 | 1,521 | 2,511 | 4,106 |
| End Cash Position | 736 | 20,946 | 8,683 | 1,521 | 2,511 |
| Net Cash Flow | $-20,210 | $12,263 | $7,162 | $-990 | $-1,595 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,750 | 11,435 | 8,445 | -2,662 | -6,016 |
| Capital Expenditure | -21 | N/A | -49 | -1 | -57 |
| Free Cash Flow | -5,771 | 11,435 | 8,396 | -2,663 | -6,073 |